Ex parte LUCAS et al. - Page 7




          Appeal No. 95-1146                                                          
          Application No. 07/913,126                                                  


          teaches that curing may be accelerated, optionally, by the                  
          inclusion of                                                                
          p-toluene-sulfonic acid.  Most of Cady's examples utilize                   
          p-toluene-sulfonic acid, not an amine, and Cady discloses a                 
          variety of ways of obtaining hydroxy functionality other than               
          the inclusion of an amine (column 2, lines 41 et seq.).                     
               We  also  do  not  find  that  TABLE  4  of  appellants'               
          specification is evidence of nonobviousness, since the data is              
          not germane to the claimed subject matter.  The compositions set            
          forth in TABLE 4 are solvent-borne compositions, whereas the                
          claimed composition is in an aqueous medium.                                
               We will not sustain the obviousness-type double patenting              
          rejection over U.S. Patent No. 4,778,869 because the claims of              
          the  patent  are  directed  to  a  copolymer  containing  ether             
          functionality, not the claimed hydroxy functionality.  Also, the            
          patented claims are directed to a polymer containing active                 
          hydrogen functionality provided by an amine, which is excluded              
          by the appealed claims.                                                     
               In conclusion, based on the foregoing, the examiner's                  
          decision rejecting the appealed claims is reversed.                         
                                      REVERSED                                        

                                         -7-                                          




Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007